Repurposing ARBs as treatments for breast cancer

Aging (Albany NY). 2017 May 31;9(5):1357-1358. doi: 10.18632/aging.101249.

Amee J George^{1

2

3}, Andrew Allen⁴, Ashwini L Chand^{5

6}

¹ The ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
² Department of Pathology, University of Melbourne, VIC, Australia.
³ School of Biomedical Sciences, University of Queensland, QLD, Australia.
⁴ Department of Physiology, University of Melbourne, VIC, Australia.
⁵ Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.
⁶ School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia.

No abstract available

Keywords: angiotensin receptor blockers; breast cancer; cardiovascular disease; mammary tumour models.

Publication types